NEDD4 over-expression regulates the afatinib resistant phenotype of NSCLC cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NEDD4 over-expression regulates the afatinib resistant phenotype of NSCLC cells

Published:2018-06 Issue:1 Volume:1 Page:19-30
ISSN:2542-5633
Container-title:Oncology Signaling
language:en
Short-container-title:Oncology Signaling

Author:

Booth Laurence,Roberts Jane L.,Poklepovic Andrew,Dent Paul

Funder

Massey Cancer Center, the Universal Inc

Dr. H.F. Young and the Betts family fund

Publisher

Elsevier BV

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference30 articles.

1. PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide;Booth;Oncotarget,2017

2. PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib];Booth;Oncotarget,2017

3. Histone deacetylases and mechanisms of regulation of gene expression;Chen;Crit Rev Oncog,2015

4. [pemetrexed + sildenafil] regulates the immunotherapy response of tumor cells;Booth;Cancer Biol Ther,2017

5. The afatinib resistance of in vivo generated H1975 lung cancer cell clones is mediated by SRC/ERBB3/c-KIT/c-MET compensatory survival signaling;Booth;Oncotarget,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The E3 ubiquitin ligase NEDD4 regulates chemoresistance to 5-fluorouracil in colorectal cancer cells by altering JNK signalling;Cell Death & Disease;2023-12-14

2. Ubiquitination/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-05

3. Identification and Validation of an Immune and Ferroptosis-Combined Index for Non–Small Cell Lung Cancer;Frontiers in Genetics;2021-11-30

4. Osimertinib-resistant NSCLC cells activate ERBB2 and YAP/TAZ and are killed by neratinib;Biochemical Pharmacology;2021-08

5. Kinase inhibitors: look beyond the label on the bottle;Cancer Drug Resistance;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3